Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, and Medical Imaging and Pathology Studies.
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities
Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Non–Small Cell Lung Cancer, Version 4.2024
The landscape of drug sensitivity and resistance in sarcoma
The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodules
Mesothelioma: Pleural, Version 1.2024
Travel to High-Volume Centers and Survival After Esophagectomy for Cancer
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Personalized chordoma organoids for drug discovery studies
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs
Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation of Non–Small Cell Lung Cancer and Metastatic Disease to the Lungs
Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Phase I Trial of Intratumoral Injection of<i>CCL21</i>Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm
Intra-arterial administration of tumor-targeting<i>Salmonella typhimurium</i>A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
Effective molecular targeting of CDK4/6 and IGF-1R in a rare <i>FUS-ERG</i> fusion <i>CDKN2A</i>-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug
Quality of patient‐reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient‐reported outcome extension: A pooled analysis of 557 trials
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas